|
|||||
|
|

Government services provider Maximus (NYSE:MMS) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 4.1% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.28 billion at the midpoint came in 3.6% below analysts’ estimates. Its non-GAAP profit of $1.85 per share was 1.6% above analysts’ consensus estimates.
Is now the time to buy MMS? Find out in our full research report (it’s free for active Edge members).
Maximus faced a challenging fourth quarter, as the market responded negatively to weaker-than-expected revenue and a lowered full-year revenue outlook. Management attributed the revenue decline primarily to delayed government contract awards and reduced volumes in its US Services and international segments. CEO Bruce Caswell noted that the temporary government shutdown led to slower payments and delays in award decisions, which hindered new project activity. The company also completed the divestiture of its child support business, shifting focus toward higher-value opportunities. Caswell emphasized, “Our first quarter results reflect virtually no direct impact to our contract portfolio from the shutdown last fall,” but acknowledged the knock-on effects of delayed awards and payments.
Looking ahead, Maximus expects its updated guidance to be driven by technology investments, particularly in automation and artificial intelligence, as well as emerging opportunities in Medicaid and SNAP (Supplemental Nutrition Assistance Program) support services. Management highlighted their recent launch of the AI-powered Accuracy Assistant tool, designed to help states reduce SNAP payment errors, and underscored the importance of upcoming Medicaid eligibility and community engagement requirements. CFO David Mutryn stated, “We continue to believe that [Medicaid and SNAP] could create a high single to low double-digit organic growth opportunity for US services… once fully ramped,” but cautioned that most new work will benefit results in 2027 and beyond.
Management pointed to delayed contract awards and lower volumes in key segments as main reasons for the quarter’s revenue miss, while highlighting progress in technology-driven services.
Maximus’s outlook centers on technology-driven service expansion, policy-driven demand in state programs, and the pace of government contract awards.
Looking forward, the StockStory team will be monitoring (1) the pace at which delayed government contracts are awarded and begin contributing to revenue, (2) adoption rates for new AI-powered tools, especially within Medicaid and SNAP programs, and (3) stabilization or improvement in US Services and international segment volumes. Execution on technology integration and the outcome of pending state legislative changes will also be watched closely for signs of accelerating growth.
Maximus currently trades at $78.00, down from $93.69 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| Mar-11 | |
| Mar-09 | |
| Mar-06 | |
| Mar-05 | |
| Feb-26 | |
| Feb-23 | |
| Feb-19 | |
| Feb-13 | |
| Feb-12 | |
| Feb-11 | |
| Feb-09 | |
| Feb-09 | |
| Feb-09 | |
| Feb-06 | |
| Feb-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite